Clinical Trial Update: A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers [EARLY_Phase 1]

View source ↗

Summary

A preliminary Phase 1 study of the amyloid imaging agent 18F-AV-45 (florbetapir F-18) in Alzheimer's disease patients and healthy elderly volunteers has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 18F-AV-45 (florbetapir F-18) (florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer Disease | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2012-05-03